Tag Archives: Seqirus

CSL Pulls Plug on Seqirus Spinoff Amid Slumping Vaccine Demand

By |
0 Comment

  CSL’s Seqirus Spinoff Put on Ice Just last week, we finally got around to covering CSL’s (CSLLY) planned spinoff of its vaccine business, Seqirus — an ambitious move intended to unlock value for CSL shareholders. Now? Never mind. In a classic case of “right idea, wrong timing,” CSL has indefinitely postponed the spinoff due to “market volatility,”… Read More »

CSL to Launch Seqirus Spinoff Business Amid Major Restructure

By |
1 Comment

CSL Limited (CSLLY), Australia’s biotech and plasma-therapeutics giant, will spin off its vaccine division, CSL Seqirus, into a separately listed entity by mid-2026. The move comes alongside a sweeping restructuring that includes job cuts, a multibillion-dollar charge, and a substantial share buyback. Seqirus Spinoff Details CSL said it plans to complete the Seqirus spinoff by June 2026, with… Read More »